Tonix Pharmaceuticals Holding Corp. (TNXP)
TNXP trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$6.13
-7.68% on the day
Market cap
$105.1M
Micro cap
Revenue · 2025
$13.1M
+29.8% on 2024
Net income · 2025
-$124.0M
-946.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | TNXP on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001430306 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $13.1M |
| Net income | -$124.0M |
| Operating income | -$125.7M |
| Net margin | -946.2% |
| Operating margin | -959.1% |
| Revenue growth | +29.8% |
| Cash | $207.6M |
| Total assets | $277.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 8.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2025-12-29 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-12 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-10-02 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-03-30 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| COYA | Coya Therapeutics Inc. | $4.47 | -6.96% | $105.0M |
| UNCY | Unicycive Therapeutics Inc. | $3.73 | -7.90% | $103.9M |
| INO | Inovio Pharmaceuticals Inc. | $0.9982 | -9.66% | $103.2M |
| CPIX | Cumberland Pharmaceuticals Inc. | $7.17 | +2.43% | $107.4M |
| RANI | Rani Therapeutics Holdings Inc. | $0.7332 | -2.36% | $102.2M |
| PMVP | PMV Pharmaceuticals Inc. | $1.35 | -4.25% | $101.9M |
| FHTX | Foghorn Therapeutics Inc. | $1.85 | -5.13% | $109.9M |
| CLLS | Cellectis S.A. | $1.10 | -6.78% | $110.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier